Gasdaska J R, Berggren M, Powis G
Arizona Cancer Center, University of Arizona, Tucson 85724, USA.
Cell Growth Differ. 1995 Dec;6(12):1643-50.
Thioredoxins are a class of low molecular weight redox proteins that undergo reversible reduction-oxidation of two active-site cysteine residues with reduction catalyzed by the NADPH-dependent flavoenzyme thioredoxin reductase. Human thioredoxin has been shown to be identical to a previously reported leukemic cell growth factor. We now report that recombinant human thioredoxin added to minimal culture medium in the absence of serum stimulates the proliferation of a number of human solid tumor cell lines measured over several days. The concentration of thioredoxin producing half-maximal stimulation of MCF-7 breast cancer cell proliferation was 350 nM, and the maximum stimulation occurred at 5 microM. The maximum increase in cell proliferation caused by thioredoxin was up to 90% of that seen with 10% bovine serum in the medium. There was a positive correlation between the ability of cell lines to proliferate in minimal medium, presumably, due to the autocrine production of growth factors by the cells, and the stimulation of proliferation by thioredoxin. Neither a redox inactive, mutant human thioredoxin, C32S/C35S, nor reduced Escherichia coli thioredoxin were able to stimulate MCF-7 cell proliferation. MCF-7 cell proliferation caused by human thioredoxin was completely abolished if the culture medium was changed each day. Antibody to thioredoxin blocked the cell proliferation caused by thioredoxin. Studies with 125I-labeled thioredoxin showed time-dependent binding to the surface of MCF-7 cells, but the binding was not saturable, indicating the absence of specific binding of thioredoxin to a cell surface receptor. Most of the thioredoxin associated with the cell could be released by trypsinization, and relatively little intact thioredoxin was taken up by the cell. The results of the study suggest that thioredoxin acts by a novel helper, redox mechanism to increase the cell proliferation response to growth factor(s) produced by the cell itself.
硫氧还蛋白是一类低分子量的氧化还原蛋白,其两个活性位点的半胱氨酸残基会发生可逆的还原-氧化反应,该还原反应由依赖于NADPH的黄素酶硫氧还蛋白还原酶催化。已证明人硫氧还蛋白与先前报道的白血病细胞生长因子相同。我们现在报告,在无血清的情况下添加到基础培养基中的重组人硫氧还蛋白在数天内可刺激多种人类实体瘤细胞系的增殖。对MCF-7乳腺癌细胞增殖产生半最大刺激作用的硫氧还蛋白浓度为350 nM,最大刺激作用出现在5 μM时。硫氧还蛋白引起的细胞增殖最大增幅高达培养基中含10%牛血清时所观察到增幅的90%。细胞系在基础培养基中增殖的能力(可能是由于细胞自分泌生长因子)与硫氧还蛋白对增殖的刺激之间存在正相关。氧化还原无活性的突变型人硫氧还蛋白C32S/C35S以及还原型大肠杆菌硫氧还蛋白均不能刺激MCF-7细胞增殖。如果每天更换培养基,人硫氧还蛋白引起的MCF-7细胞增殖将完全被消除。硫氧还蛋白抗体可阻断硫氧还蛋白引起的细胞增殖。对125I标记的硫氧还蛋白的研究表明,其与MCF-7细胞表面的结合呈时间依赖性,但该结合不饱和,表明硫氧还蛋白与细胞表面受体不存在特异性结合。与细胞相关的大部分硫氧还蛋白可通过胰蛋白酶消化释放,细胞摄取的完整硫氧还蛋白相对较少。该研究结果表明,硫氧还蛋白通过一种新的辅助氧化还原机制发挥作用,以增强细胞对自身产生的生长因子的增殖反应。